The Drug Outbreak Testing Service (DOTS) pilot study supports local experts and public health agencies experiencing a drug outbreak to identify the drug(s) behind the outbreak by providing free urinalyses of specimens already obtained from affected persons.
Up to 20 de-identified urine specimens may be submitted to DOTS and will be sent to an independent laboratory for testing for approximately 240 licit and illicit drugs, including synthetic opioids and other new psychoactive substances. Results will be provided for epidemiologic purposes only. Results are not for clinical use or legal proceedings.   
Send inquiries regarding participation to DOTS at: ndewsdots [at]
DOTS graphic